4//SEC Filing
Galletta Christopher 4
Accession 0000899243-21-016010
CIK 0001563880other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 7:04 PM ET
Size
5.5 KB
Accession
0000899243-21-016010
Insider Transaction Report
Form 4
Galletta Christopher
See Remarks
Transactions
- Award
Stock Option (right to buy)
2021-04-13+25,000→ 25,000 totalExercise: $2.53Exp: 2031-04-12→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This option was granted on April 13, 2021. The 25,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on April 12, 2022 and as to the remaining 75% of the shares in equal monthly installments thereafter, through April 12, 2025.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001486099
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 7:04 PM ET
- Size
- 5.5 KB